Zydus Cadila receives tentative approval from USFDA for Deferasirox Tablets
Zydus Cadila has received the tentative approval from the United States Food and Drug Administration (USFDA) to market Deferasirox Tablets, 90 mg, 180 mg, and 360 mg (US RLD – Exjade Tablets). It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad in the state of Gujarat. It is used to treat … Read more
